«Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents»

doi:10.21203/rs.3.rs-2095962/v1

Download PDF

Article

«Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents»

https://doi.org/10.21203/rs.3.rs-2095962/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 03 Jan, 2023

Read the published version in Scientific Reports →

You are reading this latest preprint version

Phage tail-like bacteriocins (PTLBs) are large proteomic structures similar to the tail phages. These structures function in bacterial competition by making pores in the membrane of their competitors. The PTLBs identified in Pseudomonas pneumoniae are known as R and F pyocins, which have a narrow spectrum of action. Their specificity is determined by the tail fiber and is closely related to the lipopolysaccharide type of the target competitor strain. In this study, the genome sequences of 32 clinical isolates of P. aeruginosa clinical isolates were analysed to investigate the presence of R and F pyocins, and one was detected in all strains tested. The pyocins were classified into 4 groups on the basis of the tail fiber and also the homology, phylogeny and structure of the cluster components. A relationship was established between these groups and the sequence type and serotype of the strain of origin and finally the killing spectrum of the representative pyocins was determined showing a variable range of activity between 0 and 37.5%. The findings showed that these pyocins could potentially be used for typing clinical isolates of P. aeruginosa, on the basis of their genomic sequence and cluster structure, and also as antimicrobial agents.

Health sciences/Molecular medicine

Biological sciences/Microbiology/Microbial genetics/Bacterial genetics

Phage tail-like bacteriocins

R-pyocin

F-pyocins

Sequence type

serotype

typing

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen, responsible for nosocomial infections, including bloodstream infections, pneumonia, urinary tract infections and surgical site infections ¹. This pathogen represents a serious problem in health care systems because of its capacity to acquire antibiotic resistance and its ability to produce biofilms and persist on surfaces, thereby contributing to its spread and causing outbreaks ². New antimicrobial agents as well as new typing methods are therefore required.

Bacteria utilize phage tail-like bacteriocins (PTLBs) to enable them to compete with other strains of the same species or with different species ³ and could therefore be good candidates for use as antimicrobial agents. PTLBs are large, ribosomally synthetized ⁴ protein structures (2 x 10⁶- 1 x 10⁷ KDa) encoded in the bacterial genome and structured in genetic clusters similar to the phage tail structure models, always encoding structural and assembly tail proteins, a lysis cassette and preceded by the transcription regulatory proteins ³.

P. aeruginosa produces PTLBs called pyocins, which are some of the most widely studied PTLBs and are used as a PTLBs models ³. The P. aeruginosa pyocins are grouped into three types: S-type pyocins, R-type pyocins and F-type pyocins. The S-type pyocins, not considered PTLBs, are colicin-like proteins composed by large multi domain polypeptides with DNase activity ⁵. The R-type pyocins and F-type pyocins are considered PTLBs and differ in their structure. R-type (Rigid-type) pyocins are contractile tail particles similar to the Myoviridae phage family and are composed by a long large tube surrounded by a sheath and ending in a baseplate where the receptor-binding protein (RBP) is located. The F-type (Flexible-type) pyocins are non-contractile particles, similar to the Siphoviridae phage family; they are simpler than the R-type as they do not possess a sheath, but also have an RBP ^3,6.

The killing mechanism of R-type pyocins involves the phage tail fiber possessing the RBP, which recognizes the bacterial receptor in the lipopolysaccharide (LPS); once the cell is bound, the R-type pyocin triggers contraction of the sheath by pulling the tail and the core through the envelope, forming a channel or pore that decouples the membrane potential thus inhibiting membrane transport and causing cell death ^3,7. The killing mechanism of the F-type also involves disruption of the membrane gradient, but as it lacks a tube or core that forms a channel, its mechanism of action is not yet well understood ^3,8.

To date, 5 subtypes of R-type pyocins have been described on the basis of their target specificity: R1, R2, R3, R4 and R5 ^6,9,10. Of these, R5 has the broadest spectrum, while R2 has the narrowest spectrum and encompasses the spectra of R3 and R4, that are similar. R1 is a subset of R5 but is considered a different branch. In addition, the amino acid sequence of the tail fiber protein is similar in R2, R3 and R4, but very different in R1 and R5 ^3,9,11. The F-type pyocins have been less well studied and are currently classified into three groups (F1, F2 and F3) based on their lytic spectra, although another two groups have also been identified: one in P. aeruginosa PA14 and other in P. aeruginosa M18. The former is similar to F2, identified in the reference strain P. aeruginosa PAO1, but with differences in 210 to 340 residues from the tail fiber protein; the M18 F-type shares 66% homology with the tail fiber protein of the F1 group ¹⁰.

Pyocins are encoded in gene clusters preceded by a group of regulatory genes and organised in blocks of lytic and structural genes. These clusters can be found encoding individual R-type or F-type pyocins but also in dual R-F pyocin clusters. It has previously been reported that all clusters in P. aeruginosa, i.e. both individual and the dual R-F type, are located in the genome in the intergenic region of the tryptophan operon between the trpE and trpGCD genes ^3,10. The regulatory system of both individual and dual R-type and F-type pyocins is located upstream of the cluster and is composed by an activator (prtN) and a repressor (prtR); these are related to recA, which is activated by DNA damage, cleaving prtR and producing prtN and thus activating expression of the pyocin cluster ^3,10,12. The production of both R-type and F-type pyocins in dual R-F pyocins relies on the shared regulatory system and also the shared lysis cassette, suggesting coordinated release of the dual pyocins ^6,10.

PTLBs are characterized by a narrow host spectrum, which in P. aeruginosa is known to be closely related to the LPS type of the target strain that acts as a receptor for the tail fiber proteins ¹¹. It has also been reported that each specific type of pyocin recognizes a specific serotype strain determined by the O-polysaccharide repeating portion, which acts as an O-antigen and is linked to the virulence of the strains ^11,13. The PTLBs, and more specifically the P. aeruginosa pyocins, can be used as antimicrobial agents and owing to their relationship with the O-antigen they were used in typing schemes before the emergence of molecular typing methods ^14–16. The value of pyocins as antimicrobial agents is currently being considered in research studies. The R-type pyocins were used for the first time in 1969 to rescue chick embryos infected with P. aeruginosa ¹⁷. In addition, several assays in murine models confirmed the efficacy of R-type pyocins in the treatment of infections with P. aeruginosa ^9,18,19. Due to the narrow spectrum of the PTLBs, some studies focused on generating recombinant R-type pyocins to retarget them by substituting the tail fiber protein with a phage protein in order to increase the host range in several species such as P. aeruginosa, Clostridioides difficile and Listeria monocytogenes ^8,20−23.

In the search for new pyocins, 32 genome sequences of clinical strains of P. aeruginosa of different clinical origins were analysed in the present study, and at least one pyocin cluster was identified in each strain. The sequence of these pyocins was analysed and homology and phylogenetic studies were conducted. The pyocins were isolated and purified and their killing spectrum was established, and they were also related to the serotype and sequence type (ST) of the clinical isolates.

Identification and characterization of the phage tail-like bacteriocins

Thirty-two genomic sequences of P. aeruginosa were analysed to search for PTLBs. In all of the genomes analysed, at least one cluster corresponding to a pyocin was found between tryptophan operon genes, trpE and trpG (Table 1S. Supplementary material). Thus, 21 of the strains contained a cluster that corresponded to a unique pyocin corresponding to an R-type pyocin. Dual clusters were identified in the 11 remaining strains. In the P. aeruginosa PAO1 reference strain ³, one of these clusters corresponded to a R-type pyocin, and the contiguous cluster corresponded to an F-type pyocin, both sharing the regulatory and lytic genes, as previously described for P. aeruginosa PAO1 ¹⁰.

In order to identify the PTLBs as R or F subtypes, homology analysis of the tail fiber was conducted. In the R-type pyocins, the tail fiber proteins were compared against the reference sequence for each R subtype (R1, R2, R3, R4 and R5); the results revealed that 21 of the proteins belonged to the R5 subtype, while 11 belonged to the R2 subtype, which corresponded to those that were followed by a F-type pyocin (Figure 1A, 1B). For the F-type group, the results showed a group of 5 pyocins belonging to the F2 subtype, comprising a R2-F2 pyocin, similar to the PAO1 R2-F2 pyocin³, and a group of 6 that were similar to the P. aeruginosa PA14 F-type pyocin ¹⁰, thus giving rise to a pyocin cluster R2-F(PA14) (Figure 1A,1B).

Analysis of the protein sequence of the pyocins revealed some differences in the protein number between the R5-type pyocins. Thus, these pyocins were classified in two groups, including a group of 12 pyocins (group A) constituted by an R-type cluster of 14 genes, 4 lytic genes and preceded by 5 regulator genes. The second group (group B) of 8 pyocins differed from group A in the absence of the latter protein belonging to the lytic cassette. In both groups, the cluster was preceded by the regulatory region composed by 5 genes, while in the reference P. aeruginosa PAO1 strain it is composed by 4 genes (Figure 1B) ⁵. The R2-F2 pyocins (group C) were composed by 38 genes, which corresponded to an R-type cluster of 14 proteins and a F-type cluster composed by 16 genes, while in P. aeruginosa PAO1 the F-type cluster is formed by 17 genes. In addition, the two clusters share a regulatory region of 5 genes and a lytic cassette composed by 4 proteins (Figure 1B). The pyocins R2-F(PA14) (group D) comprised two consecutive R and F clusters: the R-type comprised 14 proteins and the F-type comprised 13 proteins, unlike P. aeruginosa PAO1 and the group C pyocins, in which the last 3 proteins are duplicated (Figure 1B) ⁵.

Homology and phylogenetic analysis of pyocins

The results obtained by the homology studies of the tail fiber specificity genes were confirmed by the homology and phylogenetic analysis of the complete pyocin genomes. The homology analysis showed that the R5-type pyocins were very similar and can be grouped in two blocks corresponding to the established groups A and B, sharing a query cover value of 97-98% and an identity value of 99.35%. The pyocin H52-R5 homology BRIG differed slightly from the two blocks but had similar homology values (Figure 2). In the case of the R-F pyocin clusters, the homology results showed two blocks of homology, one corresponding to the R2-F2 pyocins (group C) and another corresponding to the R2-F(PA14) pyocin (group D) (Figure 2). Despite the presence of two groups, the pyocin clusters represented by them were also similar, with a query cover value between 88-89% and an identity value of 98%.

The phylogenetic study of all the pyocin clusters revealed, as previously observed, that the pyocins identified are divided into four phylogenetic groups. Two closely related clades of the phylogenetic tree were represented by two blocks, one corresponding to the R5-type pyocins included in group A and another also corresponding to an R5-type pyocin grouped in B. Another two closely related clades included one corresponding to group C, which was constituted by the R2-F2 pyocin and group D, constituted by the R2-F5 pyocins (Figure 3).

Identification of pyocins by Transmision Electron Microscopy (TEM)

The purified pyocins were examined by TEM, and the images obtained (Figure 4) revealed the presence of two different type of pyocins. One type had a structure similar to a tail of the viral family Myoviridae, corresponding to the R-type pyocins, observed in three conformations: a complete form, a contracted form and an empty sheath ²⁴. The other type was the F-type, observed as a flexible structure similar to a phage tail of the viral family Syphoviridae.

Relationship between the pyocin type and the source P. aeruginosa strain serotype, sequence type and clinical origin

In this analysis, the relationships between the serotype, the sequence type (ST) and the clinical origin of the source strains and the pyocin type were determined (Table 1). The R5-type pyocin in group A was almost always present in ST235 and serotype O11 clinical isolates. However, pyocin H52_pyoR5 that was quite different also in the homology and phylogenetic analysis, the pyocin H52_pyoR5, which was present in the H52 clinical isolate belonging to the ST309 but like the rest of group A has the O11 serotype. The R5-type pyocins from group B were associated with clinical isolates belonging to the ST175 with serotype O4. On the other hand, the group C of R2-F2 pyocins was the most variable, with isolates belonging to the ST348 and ST554 and serotype O5, O11 and O12. Finally, group C, constituted by R2-F(PA14) pyocins, was represented by isolates belonging to ST244 and serotypes O5 and O12. Finally, no relationship between the clinical origin of the isolate and each pyocin was observed.

Killing spectrum of the pyocins

The target range of the pyocins was studied by the spot test technique (Figure 5). The pyocins included in this analysis were selected by the ST and serotype of the strain from which they were isolated.

The results revealed a great variability in the susceptibility of the strains to the pyocins of the same subtype. In addition, no spots occurred when the target strain belonged to the same ST and serotype as the source strain of the pyocin, except for pyocin 10-58_R2-F(PA14), which produced a spot in strain 3-5, which belongs to a different ST but has the same serotype (O11). Furthermore, a variable percentage of target range was observed for all of the pyocins tested, with 9-86_pyoR2F2 showing the highest value and being able to lyse 37.5 % of the strains tested.

Pyocins are PTLBs produced by P. aeruginosa. Like all PTBLs they are protein complexes with the same structure as phage tails. Like other phage tail particles, such as the type VI secretion systems (T6SS), they also play a role in defence and in interbacterial competition ²⁵. The genetic and structural similarities between the phage tails and pyocins initially suggested that the pyocins evolved as defective phages; however, structural comparison between the T6SS, R-type pyocins and the contractile tail phages suggests evolution from a common ancestor ^3,25.

The presence of pyocins in clinical strains of P. aeruginosa seems to be variable. Thus, in a study conducted by Mei et al. ⁷, 444 respiratory isolates from cystic fibrosis (CF) patients were analysed to search pyocins, and 174 R-type pyocins, mainly of the R1 subtype, were detected. Köhler et al. ¹¹ analysed the tracheal aspirates of 61 patients, in search of R-type pyocins, detecting different R subtype pyocins in 77% of the isolates. In another study of 24 isolates from the lungs of CF patients, all isolates were found to contain R-type pyocins, also mainly of the R1 subtype, and it was concluded that this subtype confers a competitive advantage in biofilms, explaining why certain strains displace others in the CF lungs ⁴. In the present study, the genome of 32 clinical isolates of P. aeruginosa from several origins, including urinary tract infections, lower respiratory tract infections and intra-abdominal infections, were analysed in search of pyocins, and at least one cluster was found in all isolates. In contrast to the previously mentioned studies, both R-type clusters and F-type clusters were found, resulting in R pyocins and dual R-F pyocins. Analysis of the tail fiber, which determines the specificity (Fig. 1), showed that only R2, R5, F2 and F(PA14) were present in these isolates, with an equal representation of the R5 and R2 subtypes, and a lower representation of F2 than F(PA14) (Fig. 2). In other studies of CF isolates, the R1 subtype was the most commonly identified and in contrast to the results of the present study, R5 was the least well represented subtype ^4,7. In a study conducted by Köhler et al. ¹¹, pyocins from R1, R2 and R5 were found in the same proportions.

Homology modelling and phylogenetic studies of the pyocins identified in these clinical isolates confirmed the grouping of the pyocins and also revealed the great similarity between them. The main difference observed between the R2-type and the R5-type pyocins was in the genomic region corresponding to the tail fiber, and the same was observed between the F2-type and the F(PA14)-type pyocins (Fig. 3). The tail fiber region has been described as being responsible for the specificity of the pyocins, as it acts as an RBP recognizing the target in the LPS of the target bacteria ^3,6.

Analysis of the pyocins identified in the genomic sequence of the P. aeruginosa clinical isolates and the clinical ST, serotype and clinical origin established a relationship between the pyocin type and the ST and serotype, but not the clinical origin of the isolate. Although a relationship with both ST and serotype was identified, it seems that there is more variability between the serotype and the presence of pyocins than with the ST. Thus, the association between the pyocin subtype and the ST and serotype can be extended to the groups established in this work beyond the pyocin subtype, as the A and B groups, which both correspond to an R5-type pyocin, were associated with a different ST and serotype. Although the association between serotype and pyocin subtype has long been recognised ¹¹, to our knowledge the present is the first report of the relationship with ST. The relationship between the serotype and the pyocin subtype ¹¹ has always been established with the R-type cluster, but in the present study a relationship between the serotype and the F-type pyocin was demonstrated, as the group C and D pyocins only differ in the F-type cluster. Both groups were related to two different serotypes, but both share O12 and differ in O5 and O11, possibly as a consequence of the presence of the R-pyocin and the F-pyocin, which in this case would confer a competitive advantage to the strain as they are protected by different pyocins ²⁵. The observed relationship between the serotype, ST and pyocin from the clinical isolates of P. aeruginosa tested in this study suggests that the pyocins could potentially be used for typing via analysis of the cluster genomic sequences. The pyocin-serotype association has been used for bacterial typing, but unlike in the present study, the typing was based on the killing activity of a pyocin from an unknown isolate over a collection of indicator strains; this method was abandoned, as it is slow and laborious, and was substituted by molecular methods ^14–16.

The serotype in P. aeruginosa is determined by the O-antigen, which is a B-band repeating unit of LPS considered a virulence factor ¹¹. It is known that the pyocin tail fiber recognize the LPS of the competitor strains but do not recognize their own LPS as a target, so they cannot lyse those strains with the same serotype. In a study carried out in 2010, Köhler et al. ¹¹ deleted different genes responsible for the synthesis of the O-antigen and determined which LPS residues act as receptors for R1-type, R2-type and R5-type pyocins. When the 32 clinical isolates were tested against the 32 isolated pyocins, none were able to lyse the source strain or those strains with the same serotype or ST. As previously described, variability in the susceptibility to the pyocins was observed between those isolates that shared ST and/or serotype and the same type of pyocin, probably due to the frequently observed mutations in the LPS genes in CF, affecting recognition by the RBP ^7,26,27. Pyocins have been considered potential alternatives to antibiotics, and several studies have demonstrated antimicrobial activity of pyocins alone or in combination with other antimicrobials and those sharing the LPS as target ^{9,19,20,28,29}.

In this study, 32 pyocins belonging to the R5-type, R2-F2 type and R2-F(PA14) type were identified. Homology and phylogenetic analysis established four groups of pyocins (A, B, C and D), each of which was found to be related to the serotype and ST of the source strain. Pyocins are therefore good candidate markers for typing strains of P. aeruginosa by analysis of the tail fiber protein of the pyocin. We also observed that they could be used to type R5-type pyocins, by the number and distribution of the genes comprising the pyocin cluster. These pyocins also displayed potential antimicrobial activity as they were able to lyse some of the clinical isolates tested, particularly the 9–86_pyoR2-F(PA14) pyocin, which exhibited the highest range of activity.

Strains and culture conditions

Thirty-two clinical strains of P. aeruginosa isolated in Portuguese and Spanish hospitals within the framework of two multicentre studies, STEP in Portugal and SUPERIOR in Spain ³⁰, were used in the study. The origin, ST and serotype of the isolates are shown in Table 1. All strains were grown in Luria-Bertani broth (LB) medium (0.5 % NaCl, 0.5 % yeast extract, 1 % tryptone) at 37ºC and 180 rpm. LB was supplemented with agar (1.5%) when necessary.

Identification of pyocin clusters in silico

The genomes of 32 clinical isolates P. aeruginosa (NCBI BioProject: PRJNA629475) were analysed to search for pyocins. For this purpose, the anthranilate flanking genes, trpD and trpE, were identified in the search for the genes that typically compose the pyocin clusters, which have been reported to be included between these genes ³.

When the pyocin cluster sequences were distributed in several contigs, were then compared by homology and assembled using BLASTn (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and Vector NTI Advance^TM 11 (Invitrogen). The complete sequences of the pyocin clusters were annotated by RAST ³¹, HMMER (http://hmmer.org) and HHPRED ³². The pyocin cluster R2-F2 of P. aeruginosa PAO1 was used as a reference sequence, which correspond to the region between the genes PAO610-PAO648 (Genbank: AE004091.2-AE004091.2) from the Pseudomonas aeruginosa database ³³ .

Pyocin cluster type identification

The pyocin clusters types were assigned by homology with the tail fiber corresponding to the protein of the reference strain P. aeruginosa PAO1: PAO620 for the R-type pyocins and by PAO646 for the F-type pyocins ¹⁰.

These strains were compared by BLASTp against the corresponding protein of the different pyocin types: R1 (ARI05994.1), R2 (AAG04009.1), R3 (ABP93392.1), R4 (ABP93394.1), R5 (ABP93396.1), F2 (AAG04035.1) and F(PA14) (ABJ15607.1). The pyocin clusters were considered to belong to a subtype when the homology value was higher than 90%.

Homology and phylogenetic analysis

The sequences obtained for the different pyocin clusters were analysed in order to study their homology. The studies were carried out using the Easyfig 2.2.5 ³⁴ and BRIG 0.95 ³⁵ tools with the tBLASTx option. The Query Cover and Identity values were analysed with BLASTn.

The sequences were aligned and a phylogenetic tree was constructed with the bioinformatic software Geneious Prime (Dotmatics).

Extraction and concentration of phage tail-like bacteriocins

The selected strains used as sources of pyocins were cultured overnight in LB broth at 37ºC. The culture was then diluted 1:100 in LB and incubated at 37ºc and 180rpm. Once the optical density measured at a wavelength of 600 nm (OD_600nm) of 0.4 was reached, 10 µg/ml of mitomycin C (Sigma-Aldrich) was added and the culture was incubated until it turned clear. The lysed cultures were centrifuged at 4000 rpm for 10 minutes, and the supernatant with the pyocins was recovered and incubated with 1% chloroform for 30 minutes. Finally, the supernatant with the pyocins was filtered through a 45 µm filter (FILTER-LAB®PES Syringe filter).

For concentration, the pyocins were precipitated with polyethylene glycol (PEG). The pyocin solution was precipitated overnight at 4ºC with 10% PEG and 0.5M NaCl. The pyocins were collected by centrifugation for 15 minutes at 11000 rpm and 4ºC. The supernatant was discarded and the pellet suspended in SM buffer (0.1 M NaCl, 1 mM MgSO4, 0.2 M Tris-HCl, pH 7.5), to obtain a 10-fold concentration. Finally, a 1:1 volume of chloroform was added and incubated with gentle shaking for 20 minutes, and the phases were then separated by centrifugation for 10 minutes at 4000 rpm. The aqueous phase with the pyocin suspension was recovered and stored at 4ºC until use.

Pyocin Transmission Electron Microscopy (TEM)

The pyocin solutions were negatively stained in 1% aqueous uranil acetate and examined in a transmission electron microscope JEOL JEM-1011.

Pyocin killing spectrum

In order to determine the target range of each isolated pyocin, each was tested against the 32 strains from which they were isolated (Table 1). The killing activity was assayed by spot test ³⁶. Briefly, double agar layer plates were prepared with the putative host strain mixed with the soft upper agar layer (0.4 % agar). Once solidified, a drop (10 μl ) of the pyocin solution was deposited on top of the agar layer, and the plates were incubated at 37ºC for 20 h.

To differentiate the R-type and F-type pyocins from the S-type pyocins, proteinase K was added to the plates, as R and F-type pyocins are protease resistant and S-type is protease sensitive ¹⁰. In order to differentiate the pyocins from prophages induced with mitomycin C, serial dilutions were spotted on agar plates. When no individual plaques were observed at the higher dilutions, the presence of a spot was considered to be the result of the killing activity of the pyocin.

Acknowledgements

This study was financed by grant PI19/00878 awarded to M. Tomás within the State Plan for R+D+I 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) and co-financed by the ISCIII-Deputy General Directorate for Evaluation and Promotion of Research—European Regional Development Fund "A way of Making Europe" and Instituto de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI, RD16/0016/0006 and CIBER CB21/13/00084), and by the Study Group on Mechanisms of Action and Resistance to Antimicrobials, GEMARA (SEIMC, http://www.seimc.org/). M. Tomás was financially supported by the Miguel Servet Research Programme (SERGAS and ISCIII). I. Bleriot was financially supported by the pFIS program (ISCIII, FI20/00302). O. Pacios and M. López were financially supported by grantw IN606A-2020/035 and IN606C-2022/002, respectively (GAIN, Xunta de Galicia).

Author contributions

L.B., developed the experiments, analysed the results and wrote the original manuscript. M.G.A, C.O-C., I.B, O.P., M.L., L.F.-G., A.B.-P., M.H.G., visualization the results and manuscript. R.C.., M.T., re-written the manuscript, financed and directed the experiments and supervised the writing of the original manuscript.

Transparency declarations

The authors declare that there are no conflicts of interest.

Pires, D. P., Vilas Boas, D., Sillankorva, S. & Azeredo, J. Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections. J Virol 89, 7449–7456, doi:10.1128/JVI.00385-15 (2015).
de Sales, R. O., Migliorini, L. B., Puga, R., Kocsis, B. & Severino, P. A Core Genome Multilocus Sequence Typing Scheme for Pseudomonas aeruginosa. Front Microbiol 11, 1049, doi:10.3389/fmicb.2020.01049 (2020).
Scholl, D. Phage Tail-Like Bacteriocins. Annu Rev Virol 4, 453–467, doi:10.1146/annurev-virology-101416-041632 (2017).
Oluyombo, O., Penfold, C. N. & Diggle, S. P. Competition in Biofilms between Cystic Fibrosis Isolates of Pseudomonas aeruginosa Is Shaped by R-Pyocins. mBio 10, doi:10.1128/mBio.01828-18 (2019).
Nakayama, K. et al. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 38, 213–231, doi:10.1046/j.1365-2958.2000.02135.x (2000).
Ghequire, M. G. K. & De Mot, R. The Tailocin Tale: Peeling off Phage Tails. Trends Microbiol 23, 587–590, doi:10.1016/j.tim.2015.07.011 (2015).
Mei, M., Thomas, J. & Diggle, S. P. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs. mBio 12, doi:10.1128/mBio.00458-21 (2021).
Lee, G. et al. F-Type Bacteriocins of Listeria monocytogenes: a New Class of Phage Tail-Like Structures Reveals Broad Parallel Coevolution between Tailed Bacteriophages and High-Molecular-Weight Bacteriocins. J Bacteriol 198, 2784–2793, doi:10.1128/JB.00489-16 (2016).
Scholl, D. & Martin, D. W. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model. Antimicrob Agents Chemother 52, 1647–1652, doi:10.1128/AAC.01479-07 (2008).
Ghequire, M. G. & De Mot, R. Ribosomally encoded antibacterial proteins and peptides from Pseudomonas. FEMS Microbiol Rev 38, 523–568, doi:10.1111/1574-6976.12079 (2014).
Kohler, T., Donner, V. & van Delden, C. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa. J Bacteriol 192, 1921–1928, doi:10.1128/JB.01459-09 (2010).
Matsui, H., Sano, Y., Ishihara, H. & Shinomiya, T. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J Bacteriol 175, 1257–1263, doi:10.1128/jb.175.5.1257-1263.1993 (1993).
Lu, Q. et al. Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes. Crit Care 18, R17, doi:10.1186/cc13697 (2014).
Farmer, J. J., 3rd & Herman, L. G. Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage. Appl Microbiol 18, 760–765, doi:10.1128/am.18.5.760-765.1969 (1969).
Rampling, A., Whitby, J. L. & Wildy, P. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin. J Med Microbiol 8, 531–541, doi:10.1099/00222615-8-4-531 (1975).
Fyfe, J. A., Harris, G. & Govan, J. R. Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol 20, 47–50, doi:10.1128/jcm.20.1.47-50.1984 (1984).
Bird, T. J. & Grieble, H. G. Pyocin antibiosis in chick embryos. Antimicrob Agents Chemother (Bethesda) 9, 495–498 (1969).
Haas, H., Sacks, T. & Saltz, N. Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice. J Infect Dis 129, 470–472, doi:10.1093/infdis/129.4.470 (1974).
Six, A. et al. Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis. J Antimicrob Chemother 76, 2317–2324, doi:10.1093/jac/dkab199 (2021).
Williams, S. R., Gebhart, D., Martin, D. W. & Scholl, D. Retargeting R-type pyocins to generate novel bactericidal protein complexes. Appl Environ Microbiol 74, 3868–3876, doi:10.1128/AEM.00141-08 (2008).
Gebhart, D. et al. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity. mBio 6, doi:10.1128/mBio.02368-14 (2015).
Gebhart, D. et al. Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile. J Bacteriol 194, 6240–6247, doi:10.1128/JB.01272-12 (2012).
Alqahtani, A. et al. Recombinant R2-pyocin cream is effective in treating Pseudomonas aeruginosa-infected wounds. Can J Microbiol 67, 919–932, doi:10.1139/cjm-2021-0207 (2021).
Liu, J., Chen, P., Zheng, C. & Huang, Y. P. Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia. Appl Environ Microbiol 79, 5593–5600, doi:10.1128/AEM.01648-13 (2013).
Patz, S. et al. Phage tail-like particles are versatile bacterial nanomachines - A mini-review. J Adv Res 19, 75–84, doi:10.1016/j.jare.2019.04.003 (2019).
Penterman, J. et al. Rapid evolution of culture-impaired bacteria during adaptation to biofilm growth. Cell Rep 6, 293–300, doi:10.1016/j.celrep.2013.12.019 (2014).
Davis, M. R., Jr. et al. Identification of the mutation responsible for the temperature-sensitive lipopolysaccharide O-antigen defect in the Pseudomonas aeruginosa cystic fibrosis isolate 2192. J Bacteriol 195, 1504–1514, doi:10.1128/JB.01999-12 (2013).
Redero, M., Aznar, J. & Prieto, A. I. Antibacterial efficacy of R-type pyocins against Pseudomonas aeruginosa on biofilms and in a murine model of acute lung infection. J Antimicrob Chemother, doi:10.1093/jac/dkaa121 (2020).
Redero, M. et al. Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. J Antimicrob Chemother 73, 2770–2776, doi:10.1093/jac/dky261 (2018).
Hernandez-Garcia, M. et al. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS. J Antimicrob Chemother 76, 370–379, doi:10.1093/jac/dkaa430 (2021).
Overbeek, R. et al. The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res 42, D206-214, doi:10.1093/nar/gkt1226 (2014).
Gabler, F. et al. Protein Sequence Analysis Using the MPI Bioinformatics Toolkit. Curr Protoc Bioinformatics 72, e108, doi:10.1002/cpbi.108 (2020).
Winsor, G. L. et al. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res 44, D646-653, doi:10.1093/nar/gkv1227 (2016).
Sullivan, M. J., Petty, N. K. & Beatson, S. A. Easyfig: a genome comparison visualizer. Bioinformatics 27, 1009–1010, doi:10.1093/bioinformatics/btr039 (2011).
Alikhan, N. F., Petty, N. K., Ben Zakour, N. L. & Beatson, S. A. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12, 402, doi:10.1186/1471-2164-12-402 (2011).
Raya, R. R. & H'Bert E, M. Isolation of Phage via Induction of Lysogens. Methods Mol Biol 501, 23–32, doi:10.1007/978-1-60327-164-6_3 (2009).

Table 1. Characteristics of the 32 clinical isolates of P. aeruginosa which were obtained in previous study³⁰and the 32 pyocins identified. IAI: intrabdominal infection; UTI: Urinary tract infection; LRTI: Lower respiratory tract infection.

Strain	Genbank	Origin	ST	Serotype	Pyocin	Group
1-13	SAMN14776823	IAI	ST235	O11	1-13_pyoR5	A
2-29	SAMN14776826	UTI	ST235	O11	2-29_pyoR5
3-49	SAMN14776829	IAI	ST235	O11	3-49_pyoR5
4-17	SAMN14776829	UTI	ST235	O11	4-17_pyoR5
4-71	SAMN14776839	IAI	ST235	O11	4-71_pyoR5
4-79	SAMN14776840	UTI	ST235	O11	4-79_pyoR5
4-86	SAMN14776841	IAI	ST235	O11	4-86_pyoR5
4-92	SAMN14776842	UTI	ST235	O11	4-92_pyoR5
4-93	SAMN14776843	UTI	ST235	O11	4-93_pyoR5
4-94	SAMN14776844	IAI	ST235	O11	4-94_pyoR5
4-120	SAMN14776833	UTI	ST235	O11	4-120_pyoR5
4-121	SAMN14776834	UTI	ST235	O11	4-121_pyoR5
9-41	SAMN14776860	LRTI	ST235-1LV	O11	9-41_pyoR5
C11	SAMN14776862	UTI	ST175	O4	C11_pyoR5	B
C58	SAMN14776863	UTI	ST175-2LV	O4	C58_pyoR5
G6	SAMN14776870	IAI	ST175-1LV	O4	G6_pyoR5
G7	SAMN14776871	IAI	ST175-2LV	O4	G7_pyoR5
G26	SAMN14776868	IAI	ST175-1LV	O4	G26_pyoR5
G31	SAMN14776869	IAI	ST175-1LV	O4	G31_pyoR5
H18	SAMN14776872	UTI	ST175-2LV	O4	H18_pyoR5
H52	SAMN14776874	UTI	ST309	O11	H52_pyoR5
3-5	SAMN14776830	UTI	ST348-1LV	O11	3-5_pyoR2-F2
3-38	SAMN14776827	LRTI	ST348	O12	3-38_pyoR2-F2
3-41	SAMN14776828	LRTI	ST348-1LV	O12	3-41_pyoR2-F2
3-58	SAMN14776831	IAI	ST348	O11	3-58_pyoR2-F2
9-86	SAMN14776861	IAI	ST554	O5	9-86_pyoR2-F2
5-23	SAMN14776846	LRTI	ST244	O5	5-23_pyoR2-F(PA14)	D
6-25	SAMN14776848	LRTI	ST244-1LV	O12	6-25_pyoR2-F(PA14)
8-24	SAMN14776854	UTI	ST244-1LV	O5	8-24_pyoR2-F(PA14)
8-36	SAMN14776855	UTI	ST244	O5	8-36_pyoR2-F(PA14)
9-25	SAMN14776858	LRTI	ST244-1LV	O12	9-25_pyoR2-F(PA14)
10-58	SAMN14776820	LRTI	ST244	O12	10-58_pyoR2-F(PA14)

No competing interests reported.

Download PDF

Journal Publication

published 03 Jan, 2023

Read the published version in Scientific Reports →

Editorial decision: Major revision
30 Nov, 2022
Reviews received at journal
29 Nov, 2022
Reviewers agreed at journal
16 Nov, 2022
Reviews received at journal
29 Oct, 2022
Reviewers agreed at journal
19 Oct, 2022
Reviewers agreed at journal
19 Oct, 2022
Reviewers invited by journal
07 Oct, 2022
Editor assigned by journal
07 Oct, 2022
Editor invited by journal
26 Sep, 2022
Submission checks completed at journal
26 Sep, 2022
First submitted to journal
23 Sep, 2022

You are reading this latest preprint version

«Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents»

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Results

Discussion

Material And Methods

Declarations

References

table

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1